Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death

Circulation

Volumn 101, Issue 1, 2000, Pages 40-46

  Teerlink, John R ^a   Jalaluddin, Muhammad ^b   Anderson, Susan ^b   Kukin, Marrick L ^c   Eichhorn, Eric J ^d   Francis, Gary ^e   Packer, Milton ^f   Massie, Barry M ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f College of Physicians and Surgeons ^*  (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arrhythmia; Death, sudden; Heart failure; Inotropic agents; Prognosis

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MILRINONE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH;

EID: 0034602819     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.1.40     Document Type: Article

References (17)

1. Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, Stienen U, Treese N, Just H. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J. 1988;116:1455-1463.
2. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure: Captopril-Digoxin Study Group. J Am Coll Cardiol. 1989;14:564-570.
3. Rouleau J, Shenasa M, de Champlain J, Nadeau R. Predictors of survival and sudden death in patients with stable severe congestive heart failure due to ischemic and nonischemic causes: a prospective long term study of 200 patients. Can J Cardiol. 1990;6:453-460.
4. Szabo BM, van Veldhuisen DJ, Crijns HJ, Wiesfeld AC, Hillege HL, Lie KI. Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure. Eur Heart J. 1994;15:928-933.
5. Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, Dubner S, Scapin O, Perrone SV. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death: GESICA-GEMA Investigators. Circulation. 1996;94: 3198-3203.
6. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335: 1933-1940.
7. Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126:1-12.
8. Konstam M, Dracup K, Baker D, Bottorff MB, Brooks NH, Dacey RA, Dunbar SB, Jackson AB, Jessup M, Johnson JC, Jones RH, Luchi RJ, Massie BM, Pitt B, Rose EA, Rubin LJ, Wright RF, Hadorn DC. Heart Failure: Evaluation and Care of Patients With Left-Ventricular Systolic Dysfunction: Clinical Practice Guideline No. 11. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services; 1994. AHCPR publication No. 94-0612.
9. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation. 1995;92:2764-2784.
10. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM. Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL, for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research Group. N Engl J Med. 1991;325:1468-1475.
11. Singh SN, Fisher SG, Carson PE, Fletcher RD. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy: Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol. 1998;32:942-947.
12. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457-464.
13. Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675-1680.
14. Pratt CM, Gardner M, Pepine C, Kohn R, Young JB, Greenberg B, Capone R, Kostis J, Henzlova M, Gosselin G, Weiss M, Francis M, Stewart D, Davis E, Yusuf S, for the SOLVD Investigators. Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure: SOLVD Investigators. Am J Cardiol. 1995;75:1244-1249.
15. Ziesche S, Rector TS, Cohn JN. Interobserver discordance in the classification of death in studies of heart failure. J Card Fail. 1995;1:127-132.
16. Gottlieb SS. Dead is dead: artificial definitions are no substitute. Lancet. 1997;349:662-663.
17. Kürkciyan I, Meron G, Behringer W, Sterz F, Berzlanovich A, Domanovits H, Müllner M, Bankl HC, Laggner AN. Accuracy and impact of presumed cause in patients with cardiac arrest. Circulation. 1998;98:766-771.